Mechanisms of Disease: survival benefit of temsirolimus validates a role for mTOR in the management of advanced RCC
Year: 2008
Type: review
DOI: 10.1038/ncponc1173
Author: Robert A Figlin
Institutions: City Of Hope National Medical Center, City of Hope
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2026634733